Johnson and colleagues [78] successfully extended the survival of a mouse model of Leigh syndrome, which was deficient in Ndufs4 of complex I, by chronic administration of the mTOR inhibitor, rapamycin. The gene discussed is MTOR; the disease is Leigh syndrome.